Followers | 144 |
Posts | 27684 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, April 16, 2020 8:20:06 AM
into is BVXV.
A short description of the company:
About BiondVax
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is Phase 3 clinical phase bio pharmaceutical company developing the M-001 Universal Flu Vaccine. M-001 is currently undergoing a pivotal, clinical efficacy, Phase 3 trial in about 12,400 participants. Results of the clinical trial are expected by the end of 2020.
M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic. In 7 completed clinical trials the vaccine was shown to be safe, well tolerated and immunologic to a broad range of flu strains.
More at http://www.biondvax.com/
Disclosure: I own some 270 shares.
Since you are into bios, i think that this one has great
potential. Can you imagine the potential of a universal flu vaccine?
Influenza is not a hot subject nowadays, Corona took all
limelight, but its day will come - hopefully
Recent SLGL News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/19/2024 10:03:29 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/19/2024 10:01:43 AM
- Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/17/2024 03:27:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 11:15:39 AM
- Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/16/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2024 11:15:03 AM
- Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa • GlobeNewswire Inc. • 07/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/22/2024 12:05:31 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/15/2024 05:59:49 PM
- Sol-Gel Technologies Announces Management Realignment • GlobeNewswire Inc. • 07/15/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 11:17:45 AM
- Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice • GlobeNewswire Inc. • 05/28/2024 11:00:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2024 08:05:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2024 11:15:09 AM
- Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 05/20/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 10:15:07 AM
- Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel • GlobeNewswire Inc. • 05/16/2024 10:00:00 AM
- Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 01:29:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 01:07:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2024 11:49:02 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/17/2024 09:05:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 12:10:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2023 01:20:38 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM